Buspar vs Wellbutrin for Anxiety: What the Evidence Shows

If you’ve been offered Buspar or Wellbutrin for anxiety, you’ve probably noticed the generic names, buspirone and bupropion, are almost identical. That’s where the similarity ends. These two medications act on different brain systems, carry different FDA approvals, and tend to feel different in your body.

Your brain doesn’t route worry and motivation through a single channel. Buspirone has a high affinity for serotonin 5-HT1A receptors, according to its FDA prescribing information. Bupropion is a relatively weak blocker of dopamine and norepinephrine reuptake and doesn’t block serotonin reuptake, per the Wellbutrin XL prescribing information. Knowing which system a drug targets gives the choice its precision.

The usual way to choose between them is to follow the label. Buspirone is indicated for anxiety disorders, and its efficacy was shown in controlled trials of outpatients with generalized anxiety. Bupropion is approved for major depressive disorder and the prevention of seasonal depression. Those approvals rest on controlled trials, and the results are real.

But a label tells you where a drug was tested, not how it will fit your symptoms, and at Siggy we’d rather match the medication to your pattern than to the name on the box.

That’s what this guide does. It compares Buspar and Wellbutrin by mechanism, by pooled and head-to-head trial data, and by the side effects you’d actually notice. Every comparison below is grounded in trial data rather than brand reputation, so the deciding factor stays the evidence.

What This Page Covers

• What Is the Difference Between Buspar and Wellbutrin?
• Is Buspar or Wellbutrin Better for Anxiety?
• Can Wellbutrin Make Anxiety Worse?
• What Happened When the Two Were Compared Directly?
• How Do the Side Effects Compare?
• Who Is Each Medication a Better Fit For?
• Talk Through Your Options With Siggy

What Is the Difference Between Buspar and Wellbutrin?

Buspar is an anti-anxiety medication. Wellbutrin is an antidepressant. The FDA labels for both drugs spell out the core differences, summarized below.

Feature	Buspar (Buspirone)	Wellbutrin (Bupropion)
FDA-labeled use	Anxiety disorders	Depression, seasonal depression
Main target	Serotonin 5-HT1A receptors	Dopamine and norepinephrine reuptake
Controlled substance	No	No
Most common side effects	Dizziness, nausea, headache	Dry mouth, insomnia, nausea

Buspirone’s label starts at 7.5 mg twice daily, with a maximum of 60 mg per day. Wellbutrin XL starts at 150 mg once each morning and usually moves to a 300 mg target. The same active ingredient, bupropion, is also sold as Zyban to help people quit smoking.

Is Buspar or Wellbutrin Better for Anxiety?

When anxiety is the main problem, buspirone has the more direct evidence. A Cochrane review of 36 trials with 5,908 participants found that azapirones, the drug class that includes buspirone, worked better than placebo for generalized anxiety disorder. They may be less effective than benzodiazepines, and they appeared most useful for people who hadn’t taken a benzodiazepine before.

There’s a limit worth knowing. Most of those trials lasted only four to nine weeks, and the buspirone label notes that effectiveness beyond three to four weeks hasn’t been shown in controlled trials. The label does describe 264 people treated for a year without ill effect, and it advises prescribers to reassess its usefulness periodically.

Wellbutrin isn’t approved for any anxiety disorder, so using it for anxiety is off-label. Still, the evidence is more interesting than its reputation suggests. A pooled analysis of 10 trials found that bupropion and SSRIs improved anxiety symptoms in depression to a comparable degree. When depression came with high anxiety, a second analysis of the same trials found a modest edge for SSRIs, with response rates of 65.4% versus 59.4%. Nearly 17 people would need SSRI treatment instead of bupropion for one extra person to respond. Both were secondary analyses of depression trials, so they don’t show how bupropion performs in an anxiety disorder on its own.

Can Wellbutrin Make Anxiety Worse?

It can for some people, though most people in trials didn’t report it. In placebo-controlled depression trials on the Wellbutrin XL label, anxiety was reported by 5% of people on 300 mg a day of sustained-release bupropion and 3% on placebo. Insomnia was more common, at 11% versus 6%, and agitation rose to 9% at 400 mg a day.

Buspirone isn’t free of this either. On its label, nervousness was reported by 5% of people versus 1% on placebo, and a restlessness syndrome shortly after starting has been described in a small fraction of patients.

If you feel more anxious, restless, or unable to sleep after starting either medication, that’s worth reporting rather than pushing through. The Wellbutrin label specifically asks patients to watch for new anxiety, agitation, panic attacks, and insomnia, especially early in treatment or after a dose change. Our guide to Wellbutrin side effects covers what usually fades and what doesn’t.

What Happened When the Two Were Compared Directly?

The closest thing to a head-to-head trial comes from depression research. In the STAR*D augmentation trial, 565 adults who hadn’t recovered after about 12 weeks on citalopram were randomly assigned to add either sustained-release bupropion (279 people) or buspirone (286 people).

Remission rates were nearly identical, at 29.7% with bupropion and 30.1% with buspirone. Bupropion did produce a larger drop in self-reported symptoms, 25.3% versus 17.1%. Fewer people quit bupropion because of side effects, 12.5% compared with 20.6% for buspirone.

That trial studied depression, not anxiety, and both drugs were add-ons to an SSRI. It doesn’t settle which is better for anxiety on its own. What it does show is that both can play a role when a first antidepressant falls short, and that tolerability can tip the decision. Our guide on when doctors choose bupropion over SSRIs goes deeper on that choice.

How Do the Side Effects Compare?

On buspirone’s label, the most common side effects in placebo-controlled trials were dizziness (12% versus 3%), nausea (8% versus 5%), headache (6% versus 3%), and nervousness (5% versus 1%). About 10% of people in its early three- to four-week trials stopped because of a side effect. Buspirone also showed no evidence of tolerance or physical dependence, though it won’t prevent withdrawal if you’re coming off a benzodiazepine.

For bupropion, the label’s depression trials listed dry mouth (17% versus 7%), nausea (13% versus 8%), and insomnia (11% versus 6%) as more common than on placebo. Weight loss of more than 5 pounds occurred in 14% of people on 300 mg a day, compared with 6% on placebo. Bupropion also carries a dose-related seizure risk, roughly 0.1% at up to 300 mg a day of the sustained-release form. That’s why it isn’t used in people with seizure disorders, anorexia, or bulimia, or in people abruptly stopping alcohol, benzodiazepines, or seizure medicines.

Sexual side effects are a real point in bupropion’s favor. A meta-analysis of antidepressants found bupropion caused no more sexual dysfunction than placebo, while several SSRIs did. Buspirone’s label lists libido changes as infrequent. If sexual side effects pushed you off an SSRI, our patient strategies for SSRI sexual side effects may also help.

Who Is Each Medication a Better Fit For?

Buspirone often makes more sense when ongoing worry and tension lead the picture, when avoiding dependence risk matters to you, or when you’d like to steer clear of the sedation of older anti-anxiety drugs. Its labeled dosing is a regular twice-daily schedule, so it works differently from fast-acting, as-needed anxiety medicines. Our post on how long Buspar takes to work sets expectations.

Bupropion often makes more sense when depression leads, or when sexual side effects or weight gain on other antidepressants are a concern. It can be a harder fit if insomnia or a keyed-up, over-activated feeling is already part of your anxiety.

Some people take both. That decision belongs with a prescriber who knows your full medication list, because each drug has its own interaction warnings, including with MAOIs.

Whichever way you lean, a few details make the conversation faster: any history of seizures, head injury, or an eating disorder; how much alcohol you drink; past reactions to SSRIs or benzodiazepines; and whether sleep or energy is the bigger struggle right now. Most of them map to specific warnings on these drugs’ labels.

If your thoughts turn to harming yourself, or you feel unsafe, call or text 988. In an emergency, call 911. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Talk Through Your Options With Siggy

The right choice between Buspar and Wellbutrin depends on which symptoms lead, what you’ve tried before, and which side effects you can live with. Start your anonymous intake with Siggy to walk through your anxiety, mood, sleep, and past medications in your own words, without giving your name or email. It’s free, and you’ll get a downloadable summary you can share with any clinician. If medication is part of the right plan, a licensed prescriber reviews your full clinical picture before anything is prescribed, so you don’t have to retell your story from scratch. For a broader look at the options, see our guide to Buspar for anxiety.